Skip to content
LATEST
US Politics

Proposed Legislation Seeks to Authorize AI as Drug Prescribers

Proposed legislation seeks to authorize AI as a legal prescriber of medication, sparking debate over regulatory readiness, patient safety, and the future…

Proposed Legislation Seeks to Authorize AI as Drug Prescribers

New federal legislation has been introduced in the U.S. House of Representatives that would amend the Federal Food, Drug, and Cosmetic Act to classify artificial intelligence and machine learning technologies as practitioners eligible to prescribe medications. The bill, currently under review by the House Committee on Energy and Commerce, requires that such AI systems receive FDA approval and authorization from individual states to function in a prescribing capacity.

The proposal aims to address systemic healthcare gaps and reduce administrative burdens on medical professionals. Proponents argue that integrating AI into clinical workflows could improve diagnostic accuracy, increase patient adherence to medication, and lower government healthcare expenditures by streamlining medical operations.

Federal Food

However, medical experts have raised significant concerns regarding the current maturity of the technology and the lack of specific regulatory frameworks within the bill. Critics note that the legislation does not define which classes of drugs would be eligible for AI-led prescriptions, nor does it clarify whether human physician oversight would be a mandatory requirement for high-risk medications.

Industry observers suggest that if such technology is to be deployed, it will likely face a high regulatory threshold similar to that of autonomous vehicles. While some experts acknowledge the potential for AI to augment clinical decision-making, professional medical organizations maintain that these tools should serve to complement, rather than replace, the judgment of human clinicians.

This legislative effort follows a previous, unsuccessful attempt to introduce similar measures in 2023. The bill's progress remains uncertain as policymakers continue to balance the rapid advancement of medical technology against the need for patient safety and institutional accountability in healthcare delivery.

More stories

Latest news